SEC Form 4 · accession 0000921895-16-004799
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 31, 2016
Accepted (ET)
Jun 2, 2016 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2016 | S | 18,110 | $1.90 | D | 5,358,735 | D | |
| Common Stock | May 31, 2016 | S | 1,890 | $1.905 | D | 5,356,845 | D | |
| Common Stock | May 31, 2016 | S | 19,700 | $1.92 | D | 5,337,145 | D | |
| Common Stock | May 31, 2016 | S | 300 | $1.9201 | D | 5,336,845 | D | |
| Common Stock | May 31, 2016 | S | 23,837 | $1.93 | D | 5,313,008 | D | |
| Common Stock | May 31, 2016 | S | 100 | $1.9301 | D | 5,312,908 | D | |
| Common Stock | May 31, 2016 | S | 600 | $1.9315 | D | 5,312,308 | D | |
| Common Stock | May 31, 2016 | S | 300 | $1.935 | D | 5,312,008 | D | |
| Common Stock | May 31, 2016 | S | 56,954 | $1.94 | D | 5,255,054 | D | |
| Common Stock | May 31, 2016 | S | 790 | $1.945 | D | 5,254,264 | D | |
| Common Stock | May 31, 2016 | S | 6,755 | $1.95 | D | 5,247,509 | D | |
| Common Stock | Jun 1, 2016 | S | 4,800 | $2.00 | D | 5,242,709 | D | |
| Common Stock | Jun 1, 2016 | S | 4,650 | $2.005 | D | 5,238,059 | D | |
| Common Stock | Jun 1, 2016 | S | 1,428 | $2.01 | D | 5,236,631 | D | |
| Common Stock | Jun 1, 2016 | S | 20,000 | $2.10 | D | 5,216,631 | D | |
| Common Stock | Jun 1, 2016 | S | 9,036 | $2.17 | D | 5,207,595 | D | |
| Common Stock | Jun 1, 2016 | S | 200 | $2.18 | D | 5,207,395 | D |
Table II — derivative securities
No Table II lines on this filing.